Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $765.8 billion, total revenue of $170.61 billion and a weighted average PE ratio of 42.55.
Market Cap
765.8B
Revenue
170.61B
Profits
18B
PE Ratio
42.55
Profit Margin
10.55%
Dividend Yield
0.21%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 211.18B | -0.71% | 2,939,446 | 46.34B |
| 2 | DHR | Danaher Corporation | 134.62B | -0.52% | 6,849,447 | 25.11B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 42.94B | 0.92% | 437,283 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 39.14B | -0.84% | 1,516,451 | 7.23B |
| 5 | NTRA | Natera, Inc. | 37.52B | -1.02% | 699,314 | 2.50B |
| 6 | WAT | Waters Corporation | 36.79B | -2.02% | 819,189 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 34.72B | 0.35% | 1,089,778 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 29.37B | -1.41% | 1,300,910 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.82B | -0.35% | 187,720 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.15B | -0.02% | 1,542,111 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 24.34B | 1.98% | 916,281 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 19.54B | -1.91% | 1,884,831 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.79B | -0.73% | 492,279 | 2.78B |
| 14 | ICLR | ICON Public Limited Company | 12.70B | -2.68% | 757,704 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.32B | -2.39% | 1,117,827 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 10.91B | -1.18% | 476,147 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.56B | -0.19% | 1,835,108 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 5.80B | -2.22% | 479,105 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 5.62B | -2.35% | 1,044,783 | 409.48M |
| 20 | SHC | Sotera Health Company | 4.95B | -0.80% | 2,426,484 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.84B | 0.97% | 605,344 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.52B | -2.19% | 589,698 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.56B | -0.18% | 2,819,915 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.91B | -3.58% | 350,425 | 156.12M |
| 25 | CDNA | CareDx, Inc. | 1.92B | -1.25% | 481,185 | 412.82M |
| 26 | NEO | NeoGenomics, Inc. | 1.81B | -2.46% | 1,992,831 | 745.97M |
| 27 | WGS | GeneDx Holdings Corp. | 1.75B | -6.75% | 429,408 | 442.68M |
| 28 | PSNL | Personalis, Inc. | 1.23B | -3.60% | 2,900,374 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 921.21M | 4.27% | 2,549,094 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 748.69M | -3.12% | 408,968 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 558.64M | -1.55% | 145,672 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 529.85M | -1.58% | 867,629 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 227.83M | -1.43% | 90,514 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 153.06M | -4.44% | 74,354 | 1.95M |
| 35 | XGN | Exagen Inc. | 113.07M | -5.45% | 186,972 | 68.38M |
| 36 | BNR | Burning Rock Biotech Limited | 94.39M | - | 171 | 74.58M |
| 37 | PRPO | Precipio, Inc. | 42.32M | 3.50% | 38,466 | 25.83M |
| 38 | ADVB | Advanced Biomed Inc. | 31.36M | 13.11% | 4,725,602 | - |
| 39 | QUCY | Quantum Cyber N.V. | 24.59M | -2.70% | 607,330 | 537.08K |
| 40 | MDXH | MDxHealth SA | 21.06M | -2.91% | 391,942 | 110.97M |
| 41 | XWEL | XWELL, Inc. | 8.87M | - | 31,773 | 28.83M |
| 42 | MBAI | Check-Cap Ltd. | 8.02M | -5.98% | 15,878 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 6.17M | -7.07% | 7,652 | - |
| 44 | BIAF | bioAffinity Technologies, Inc. | 2.99M | -1.18% | 131,167 | 5.66M |
| 45 | ISPC | iSpecimen Inc. | 2.83M | -11.66% | 49,914 | 1.03M |